- Home
- SILC vs ORMP Comparison
SILC vs ORMP Comparison
Compare SILC & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILC
- ORMP
- Stock Information
- Founded
- SILC 1987
- ORMP 2002
- Country
- SILC Israel
- ORMP United States
- Employees
- SILC N/A
- ORMP N/A
- Industry
- SILC Computer Manufacturing
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- SILC Technology
- ORMP Health Care
- Exchange
- SILC Nasdaq
- ORMP Nasdaq
- Market Cap
- SILC 104.7M
- ORMP 90.7M
- IPO Year
- SILC 1994
- ORMP N/A
- Fundamental
- Price
- SILC $16.60
- ORMP $2.15
- Analyst Decision
- SILC Hold
- ORMP Hold
- Analyst Count
- SILC 2
- ORMP 1
- Target Price
- SILC N/A
- ORMP N/A
- AVG Volume (30 Days)
- SILC 16.6K
- ORMP 529.5K
- Earning Date
- SILC 01-30-2025
- ORMP 03-05-2025
- Dividend Yield
- SILC N/A
- ORMP N/A
- EPS Growth
- SILC N/A
- ORMP N/A
- EPS
- SILC N/A
- ORMP 0.11
- Revenue
- SILC $58,114,000.00
- ORMP N/A
- Revenue This Year
- SILC $6.22
- ORMP N/A
- Revenue Next Year
- SILC $19.10
- ORMP N/A
- P/E Ratio
- SILC N/A
- ORMP $19.64
- Revenue Growth
- SILC N/A
- ORMP N/A
- 52 Week Low
- SILC $11.35
- ORMP $2.00
- 52 Week High
- SILC $18.24
- ORMP $3.67
- Technical
- Relative Strength Index (RSI)
- SILC 47.87
- ORMP 39.89
- Support Level
- SILC $16.35
- ORMP $2.16
- Resistance Level
- SILC $17.46
- ORMP $3.09
- Average True Range (ATR)
- SILC 0.63
- ORMP 0.16
- MACD
- SILC -0.09
- ORMP -0.01
- Stochastic Oscillator
- SILC 17.11
- ORMP 4.08
About SILC Silicom Ltd
Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters; Edge Networking Solutions; FPGA Based Cards; x86 Open Appliances Bypass Switches and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.